Clinical Trials in New York

Showing 3981-4000 of 22,668 trials

Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

NCT02921022

The purpose of this study is to test any good and bad effects of the study drug called PEGPH20. PEGPH20 alone is considered investigational. The Food and Drug Administration (FDA) has not approved the marketing or sale of PEGPH20, but have authorized its use in research studies with humans. PEGPH20 could shrink the cancer but it also can cause side effects. PEGPH20 is an enzyme that breaks down a specific tissue component called hyaluronan produced by some tumors. Pancreatic tumors often have a large amount of hyaluronan. The removal of hyaluronan from tumors may decrease tumor growth.

Pancreatic CancerAdvanced Pancreatic Ductal Adenocarcinoma

Memorial Sloan Kettering Cancer Center110 participantsStarted Oct 2016

Hartford, Connecticut, United States • Miami, Florida, United States • Basking Ridge, New Jersey, United States +7 more locations

Active Not RecruitingPhase 2< 1 mile

Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT02570542

The purpose of this study is to study the impact of stem cell dose on outcome after autologous transplant.

Diffuse Large B-cell Lymphoma (DLBCL)Relapsed Diffuse Large B-cell Lymphoma (DLBCL)Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Memorial Sloan Kettering Cancer Center59 participantsStarted Oct 2015

Omaha, Nebraska, United States • Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States +11 more locations

Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Find Trials by Condition in New York

CAR-T Cell Therapy for Desensitization in Kidney Transplantation

Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias

Infrared Images for Spinal Cord Stimulation in Complex Regional Pain Syndrome Patients

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities

A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain.

Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome

Analysis of Donor Biopsy Tissue Samples at the Time of Kidney Transplant

Autologous Bone Marrow Aspirate Treatment for Early-Stage Osteonecrosis

This Study Aims to Find the Best Dose of BI 907828 (Brigimadlin) in Patients With Different Types of Advanced Cancer (Solid Tumors)

A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation

Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease

Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma

A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients

ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19

Motiva Flora® Aesthetic Breast Recon® Clinical Study